Use cautionDrug recall · FDA · Published April 22, 2025
RemedyRePack Recalls Clindamycin Capsules Due to CGMP Deviations
RemedyRePack Inc. recalls specific lots of Clindamycin HCl Capsules, 300 mg due to current Good Manufacturing Practice deviations in a shared facility.
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Take action
Contact the company
📍Recalling firmRemedyRePack Inc.625 Kolter Dr Ste 4 · Indiana, PA 15701-3571
✎ GovInfoNow plain-language explainer
RemedyRePack Inc. is recalling Clindamycin HCl Capsules, 300 mg, repackaged at their Indiana, PA facility. The recall addresses Current Good Manufacturing Practice (CGMP) deviations because the products were manufactured in a shared facility with Ezetimibe tablets. The record does not specify the exact nature of the contamination or cross-contamination risk beyond this manufacturing deviation. Read more at govinfonow.com/recall/32122-remedyrepack-recalls-clindamycin-capsules-due-to-cgmp-deviations.
“RemedyRePack Recalls Clindamycin Capsules Due to CGMP Deviations.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32122-remedyrepack-recalls-clindamycin-capsules-due-to-cgmp-deviations. Based on FDA recall #D-0411-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0411-2025%22&limit=1).
The FDA announced on April 22, 2025, that RemedyRePack Inc. is recalling Clindamycin HCl Capsules due to CGMP deviations involving a shared facility with Ezetimibe tablets. The agency issued recall number D-0411-2025 for the Class II voluntary recall.
How to tell if you have it
Brand: RemedyRePack
Product: Clindamycin HCl Capsules, 300 mg, 30 capsules per bottle
NDC#: 70518-3772-02
Lot codes: B3698036-033125, B3688703-032625
Expiration date: 07/31/2026
Distribution: Pennsylvania, Virginia, Florida
The hazard
The recall stems from CGMP deviations because the products were manufactured in a shared facility with Ezetimibe tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show RemedyRePack Inc. has 35 other recalls on record since February 18, 2015. Recent brand recalls include Clindamycin Capsules on March 24, 2025, Carvedilol Tablets on January 24, 2025, and Duloxetine 60mg capsules on December 2, 2024. Other recent recalls of similar products include Baxter Clindamycin Injection Recall (August 6, 2026) and Baxter Clindamycin Injection Recall (August 6, 2026).
How to tell if you have this one
Check your medication bottle for NDC# 70518-3772-02 and Lot numbers B3698036-033125 or B3688703-032625. The expiration date is 07/31/2026, and the product contains 30 capsules per bottle.
Brand
RemedyRePack
Category
Drug
Based on the official FDA remedy
What to do — step by step
Contact Your Pharmacist
Reach out to your pharmacy or healthcare provider immediately to verify if you have the recalled lots and to discuss alternative treatment options.
Do Not Take Recalled Lots
If you possess medication with the identified lot numbers, do not consume it until you have received guidance from your healthcare provider.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “Within U.S - PA, VA, FL.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Pennsylvania, Virginia.
Recall timeline
FDA published this recall 22 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0411-2025 (April 22, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0411-2025 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.